Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CISPLATIN Cause Febrile bone marrow aplasia? 136 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 136 reports of Febrile bone marrow aplasia have been filed in association with CISPLATIN (CISplatin). This represents 0.3% of all adverse event reports for CISPLATIN.

136
Reports of Febrile bone marrow aplasia with CISPLATIN
0.3%
of all CISPLATIN reports
23
Deaths
106
Hospitalizations

How Dangerous Is Febrile bone marrow aplasia From CISPLATIN?

Of the 136 reports, 23 (16.9%) resulted in death, 106 (77.9%) required hospitalization, and 29 (21.3%) were considered life-threatening.

Is Febrile bone marrow aplasia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CISPLATIN. However, 136 reports have been filed with the FAERS database.

What Other Side Effects Does CISPLATIN Cause?

Off label use (4,359) Disease progression (3,746) Neutropenia (3,095) Febrile neutropenia (3,010) Nausea (2,923) Drug ineffective (2,608) Thrombocytopenia (2,565) Anaemia (2,530) Vomiting (2,326) Diarrhoea (2,022)

What Other Drugs Cause Febrile bone marrow aplasia?

VINCRISTINE (912) METHOTREXATE (880) CYCLOPHOSPHAMIDE (839) CYTARABINE (733) PEGASPARGASE (668) DOXORUBICIN (623) DEXAMETHASONE (555) CARBOPLATIN (440) ETOPOSIDE (413) HYDROCORTISONE (379)

Which CISPLATIN Alternatives Have Lower Febrile bone marrow aplasia Risk?

CISPLATIN vs CISPLATIN\CYTARABINE\DEXAMETHASONE CISPLATIN vs CITALOPRAM CISPLATIN vs CITALOPRAM HYDROBROMIDE CISPLATIN vs CITALOPRAM\CITALOPRAM HYDROBROMIDE CISPLATIN vs CITICOLINE

Related Pages

CISPLATIN Full Profile All Febrile bone marrow aplasia Reports All Drugs Causing Febrile bone marrow aplasia CISPLATIN Demographics